Visalytics
Visalytics
approved EB-2 (NIW)

Ph.D. Student

Materials Science Engineering · China · 2025-05-29

Processing Time
341 days
Decision Date
2025-05-29
Location
California
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research into advanced nanomedicines, specifically focusing on nanoparticle-based drug delivery systems. Her work involves developing porous silicon nanoparticles designed for the improved delivery of siRNA and proteins to intracellular targets to treat cancer, brain injuries, and toxin exposure. The goal is to create both prophylactic and responsive therapeutic platforms for acute and chronic illnesses.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor impacts U.S. healthcare and biodefense by advancing medical countermeasures against emerging threats.

2 Well-positioned to Advance the Endeavor Met

The petitioner's publication record in leading journals and history of receiving funding from the NIH demonstrates her position to succeed.

3 Balance of Interests Met

The pressing relevance of the research to U.S. national interest makes it beneficial to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the applicant's record of five peer-reviewed articles and two abstracts in high-impact journals with 22 citations. Her work's strategic relevance was evidenced by funding from the National Institutes of Health (NIH) and the National Natural Science Foundation of China. The legal team successfully demonstrated that the case met all three Dhanasar prongs through robust academic qualifications and alignment with national biodefense priorities.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Government Alignment

Similar Cases

Assistant Professor

Pharmaceuticals · Syria

WeGreened EB-2 (NIW) approved
65 days 2022-03-23
The petitioner proposes to continue research in the development of new drug delivery carriers based on nanotechnology using a one-step reproducible process. This work focuses on developing DNA and RNA vaccines and treating diseases such as cancer, Alzheimer's, and diabetes. Additionally, the endeavor includes the development of new pediatric drugs designed to mask unpleasant tastes to ease ingestion for children.
View Case

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) approved
North Carolina 132 days 2024-05-17
The petitioner proposes to continue her research in pharmaceutical sciences, specifically focusing on advancing drug repurposing and the development of nanoparticle-based delivery systems. Her work aims to create smarter, more efficient ways to deliver medications for critical diseases such as cancer and COVID-19. This research is intended to provide faster, cost-effective pathways for translating laboratory discoveries into viable clinical treatments.
View Case

Postdoctoral Researcher

Nanotechnology · Jordan

WeGreened EB-2 (NIW) approved
Maryland 90 days 2023-05-13
The petitioner proposes to improve the delivery of mRNA therapeutics to increase the effectiveness of gene therapies for incurable conditions. His work focuses on formulating and characterizing novel nanoparticles and developing advanced animal models to test therapeutics for brain diseases like Alzheimer's and anti-cancer drug delivery.
View Case

Postdoctoral Researcher

Biotechnology · Bangladesh

WeGreened EB-2 (NIW) approved
Massachusetts 309 days 2025-04-01
The petitioner proposes to continue research in the United States focused on synthesizing tumor-targeted nanocarriers for RNA therapeutic delivery and improving mRNA purification systems. This work aims to develop cost-effective and scalable solutions for cancer vaccines and RNA-based therapies. The endeavor is designed to address critical challenges in cancer therapy and vaccine manufacturing.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Materials Science cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-05-29.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 341 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist